Yun Cao
Haikou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
XIAP-ULK1-mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease.
Journal: Autophagy
Published: October 26, 2025
Bixin prevents tubulointerstitial fibrosis in hyperuricemic nephropathy via promoting PPARγ-NLRP3 interaction.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 16, 2025
The natural compound stachyose targets SGLT2-mediated metabolic reprogramming to ameliorate diabetic kidney disease.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 06, 2025
Unfolded protein response-activated NLRP3 inflammasome contributes to pyroptotic and apoptotic podocyte injury in diabetic kidney disease via the CHOP-TXNIP axis.
Journal: Cellular signalling
Published: August 17, 2024
RBBP6-Mediated ERRα Degradation Contributes to Mitochondrial Injury in Renal Tubular Cells in Diabetic Kidney Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 12, 2024
The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy.
Journal: Cell reports. Medicine
Published: January 03, 2024
Fasudil attenuates oxidative stress-induced partial epithelial-mesenchymal transition of tubular epithelial cells in hyperuricemic nephropathy via activating Nrf2.
Journal: European journal of pharmacology
Published: December 16, 2023
STING contributes to lipopolysaccharide-induced tubular cell inflammation and pyroptosis by activating endoplasmic reticulum stress in acute kidney injury.
Journal: Cell death & disease
Published: October 15, 2023
Genetic Variants in MIR3142HG Contribute to the Predisposition of IgA Nephropathy in a Chinese Han Population.
Journal: Public health genomics
Published: September 01, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026